Purdue Pharmaceutical Products

Purdue Pharma is a private pharmaceutical company primarily recognized for its focus on pain management and the development of the blockbuster opioid medication OxyContin. Since its acquisition by the Sackler family in 1952, the company expanded its portfolio to include various analgesics, antiseptics, and laxatives. Purdue became the subject of intense legal scrutiny and thousands of lawsuits for its marketing practices, which were alleged to have significantly contributed to the opioid crisis in the United States. In 2019, the company filed for Chapter 11 bankruptcy as part of a settlement plan to reorganize into a public benefit corporation dedicated to addressing the opioid epidemic.